FurosemideThird Party Manufacturing in India

Furosemide is a potent loop diuretic that works by inhibiting the sodium-potassium-chloride (Na⁺-K⁺-2Cl⁻) cotransporter in the thick ascending limb of the loop of Henle in the kidney. This inhibition prevents the reabsorption of sodium, chloride, and potassium ions from the tubular fluid back into the bloodstream. The resulting increase in osmotic pressure within the renal tubule draws water along with these ions, producing a profound diuretic effect. Unlike thiazide diuretics that act on the distal convoluted tubule, furosemide's action on the loop of Henle gives it a much higher ceiling of efficacy, making it effective even in patients with moderate to severe renal impairment. The drug also causes increased excretion of magnesium and calcium, though to a lesser extent than sodium. Onset of action after oral administration is within 30 to 60 minutes, with peak effect at 1 to 2 hours and duration of 6 to 8 hours. Intravenous furosemide acts within 5 minutes, making it invaluable in acute settings. The drug is highly bound to plasma proteins and is eliminated primarily by renal excretion as unchanged drug and as a glucuronide metabolite.

Therapeutic Uses

Furosemide is prescribed for the treatment of:

• Edema associated with congestive heart failure: Reduces fluid overload, pulmonary congestion, and peripheral edema, improving symptoms and functional capacity in patients with CHF.
• Edema in liver cirrhosis and renal disease: Manages ascites and peripheral edema in cirrhotic patients and controls fluid retention in nephrotic syndrome and chronic kidney disease.
• Hypertension: Used alone or in combination with other antihypertensives, particularly in patients with reduced kidney function where thiazides may be ineffective.
• Acute pulmonary edema: Given intravenously as adjunctive therapy for rapid reduction of fluid in the lungs, often in emergency or critical care settings.
• Hypercalcemia: Off-label use to increase renal calcium excretion in severe hypercalcemia.

Why Manufacturers Choose Furosemide

Furosemide is one of the most widely prescribed diuretics globally and appears on the WHO Model List of Essential Medicines. Its demand spans hospital formularies, chronic care programs, and emergency medicine, ensuring consistent year-round volume for manufacturers. Indian manufacturers are well-positioned to produce furosemide tablets at competitive prices due to established API supply chains and cost-efficient solid dosage production capabilities. The drug is available in multiple strengths — 20mg, 40mg, 80mg, and 500mg — allowing manufacturers to serve both routine outpatient and high-dose hospital segments. Furosemide is among the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators, institutional buyers, and export-oriented companies.

Dosage Forms

• Tablet: 20mg, 40mg, 80mg, 500mg
• Injection: 10mg/mL (2mL and 4mL ampoules)